Nobuko Maki

408 citations
10 papers · 283 indexed · h-index 6
Topics
Legionella and Acanthamoeba research (6 papers)Pneumonia and Respiratory Infections (6 papers)Acute Myeloid Leukemia Research (2 papers)
Partner nations
Japan

In The Last Decade

Nobuko Maki

10 papers receiving 274 citations

Peers

Nobuko Maki
Comparison fields: 5 of 40
  • Microbiology 163
  • Physiology 85
  • Endocrinology 76
  • Epidemiology 75
  • Molecular Biology 41
Replace Ricardo García Luján with:
Ricardo García Luján Spain
Cameron Buckley Australia
Patrick Descheemaeker Belgium
Michelle Shuel Canada
O. Horovitz Israel
Richard E. Kaufman United States
M.L. Garlaschi Italy
Anu Nurkka Finland
Tavleen Kaur Jaggi Singapore
Kohsuke Mizutani Japan
Nobuko Maki relative to Ricardo García Luján Spain Ricardo García Luján's profile →
Citations per field
00.5×7.3×
Ricardo García Luján · 1×
Citations per year

Countries citing papers authored by Nobuko Maki

Since Specialization
Citations

This map shows the geographic impact of Nobuko Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Maki more than expected).

Fields of papers citing papers by Nobuko Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Maki. The network helps show where Nobuko Maki may publish in the future.

Co-authorship network of co-authors of Nobuko Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Maki. A scholar is included among the top collaborators of Nobuko Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Maki. Nobuko Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 37
3 20
4 4
5 2
6 12
7 28
8 164
9 12
10
[Prognostic significance of CD7 expression in adult acute myeloid leukemia].
3

About Nobuko Maki

Nobuko Maki is a scholar working on Endocrinology, Molecular Medicine and Microbiology, having authored 10 papers that have together received 283 indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (6 papers), Pneumonia and Respiratory Infections (6 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Microbiology (163 citations), Endocrinology (76 citations) and Molecular Medicine (32 citations). Nobuko Maki has collaborated with scholars based in Japan. Frequent co-authors include Masahiro Takahata, Yukihiko Oishi, Hirokazu Goto, Shoichi Onodera, Shinzaburo Minami, Katsuhisa Endo, Hiroo Suzuki, Toshiaki Kikuchi, Kazuhiro Tateda and Yosuke Aoki. Their work appears in journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Infection and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026